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Abstract 
Background:    Very early aphasia rehabilitation studies have shown mixed results. Differences in 
therapy intensity and therapy type contribute significantly to the equivocal results.  
Aims:   To compare a standardised, prescribed very early aphasia therapy regimen to a historical 
usual care control group at therapy completion (4-5 weeks post-stroke) and again at follow-up (six 
months).  
 Method and Procedures: This study compared two cohorts from successive studies conducted in 
four Australian acute/subacute hospitals. The studies had near identical recruitment, blinded 
assessment and data collection protocols. The Very Early Rehabilitation (VER) cohort (N=20) had 
mild-severe aphasia and received up to 20 one-hour sessions of impairment-based aphasia therapy, 
for up to five weeks. The control cohort (n=27) also had mild-severe aphasia and received usual 
care (UC) therapy for up to four weeks post-stroke. The primary outcome measure was the 
Aphasia Quotient (AQ) and a measure of communicative efficiency (DA) at therapy completion. 
Outcomes were measured at baseline, therapy completion and six months post stroke and were 
compared using Generalised Estimating Equations (GEE) models.  
Outcomes and Results: After controlling for initial aphasia and stroke disability the GEE models 
demonstrated that at the primary endpoint, participants receiving VER achieved 18 percent greater 
recovery on the AQ  and 1.5 percent higher DA scores  than those in the control cohort. At six 
months, the VER participants maintained a 16 percent advantage in recovery on the AQ and 0.6 
percent more on DA scores over the control cohort participants. 
Conclusions and implications:  A prescribed, impairment-based aphasia therapy regimen, 
provided daily in very early post-stroke recovery, resulted in significantly greater communication 
gains in people with mild-severe aphasia at completion of therapy and at six months, when 
compared to a historical control cohort. Further research is required to demonstrate large-scale and 
long-term efficacy.  
 
 
 3 
 
 
What this paper adds 
What is already known about the subject: 
The outcomes of very early aphasia therapy are the subject of ongoing debate. Given the 
potentially devastating impact of aphasia, very early rehabilitative therapy for people with aphasia 
requires further investigation. 
 
What this study adds: 
Very early aphasia intervention, provided as 20 sessions over 4- 5 weeks, resulted in significantly 
greater communication gains than usual care. It adds to evidence suggesting increased aphasia 
therapy (intensity, frequency and amount) in the very early and early recovery phases are 
important for augmenting the effects of spontaneous recovery.  
 
 
Background 
  Aphasia is a devastating condition that affects up to 42% of first-ever stroke survivors 
(Engelter et al, 2006). Up to 50% of these people may still suffer aphasia at 18 months (Davidson 
et al. 2008). The negative effects of aphasia have wide ranging social and financial implications 
with few people with aphasia regaining full independence (Davidson et al, 2008).  People with 
aphasia consume greater healthcare resources (Morris, Franklin & Menger, 2011), report higher 
levels of social and emotional isolation (Davidson et al, 2004; Kauhanen et al. 2000) and higher 
incidences of major depression within the first 12 months post stroke, than stroke survivors 
without aphasia (Kauhanen et al. 2000).  
The mainstay for aphasia recovery is rehabilitation. The "earlier is better" concept is 
supported by small randomised controlled trials (Bakheit et al, 2007; de Jong-Hagelstein et al, 
2011; Godecke et al. 2012) and comparative studies, which suggest that 2-5 hours of impairment 
based therapy per week, provides improved recovery (Bhogal et al. 2003, Robey 1998).
 
The first 
90 days post stroke are believed to be the "window of opportunity” for neuronal changes to occur 
as part of neuroplasticity (Meyer et al, 2010).
 
The positive effects of early aphasia rehabilitation 
are thought to be underpinned by neural substrates that enable brain recovery in the immediate 
post stroke period. Very early (acute) and early (subacute) post stroke aphasia rehabilitation is 
believed to harness the effects of spontaneous recovery through therapeutic activities that include 
high levels of "repetition and intensity", "task specific practice" and therapy "saliency” (Raymer et 
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al, 2008). The process of recovery is thought to be driven by the strengthening of neural networks. 
Neural strengthening requires repeated, synchronous firing of a group of neurons (Berthier & 
Pulvermuller, 2011). This repeated synchronous neuronal firing is achieved through high 
frequency task repetition, and is thought to minimise independent neuronal activation that 
potentially produces maladaptive behaviours (Berthier & Pulvermuller, 2011). Implementation of 
the above neuroplasticity principles is aimed at strengthening the neural networks, used for 
communication, when the brain has its greatest potential for recovery (Kreisel, Hennerici & 
Hansjorg, 2007). It is believed that these activities lead to significant changes in communication 
abilities when delivered in manageable doses starting within the first two weeks post stroke 
(Godecke et al. 2012).  
The clinical effects however, of very early aphasia therapy are equivocal. This is due to 
methodological difficulties related to the implementation of large scale trials to address the aphasia 
efficacy debate. In particular, issues in early recovery include identifying: i) the optimum therapy 
intensity, ii) the ideal therapy type to accommodate the enormous variability in aphasia 
presentation and iii) selecting people with aphasia who will benefit from rehabilitation.  The 
Cochrane Review (Brady et al. 2012) reported a trend in evidence to support aphasia intervention, 
with further research required to confirm these findings. There is little evidence from the Cochrane 
Review (Brady et al. 2012) regarding the efficacy of aphasia therapy started in the very early or 
early recovery phase. 
Current Research on Early and Very Early Aphasia Therapy 
The following summary provides an overview of the most recently published clinical trials 
in early aphasia rehabilitation. For a comprehensive overview see Brady et al. (2012). de Jong- 
Hagelstein et al. conducted  a RCT to investigate the role of therapy type in early aphasia recovery, 
with  aphasia therapy commencing within three weeks of stroke onset.  Participants (N=80) 
received an equal amount of therapy (mean of 45.4 hours) at a low intensity level (2.1 hours per 
week,). The primary outcome measure was the Amsterdam-Njimegen Everyday Language Test 
ANELT (Blomert, Koster & Kean 1995) at three and six months post stroke.  The intervention 
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group received a cognitive linguistic approach to treatment consisting of a semantically based 
treatment, BOX and/or a phonological treatment programme, FIKS. The control group received 
PACE therapy (Promoting Aphasic Communication Effectiveness) (Davis & Wilcox 1985), role 
playing and conversational coaching. Both groups (N=80) made positive change on the ANELT at 
three and six months post stroke, with the majority of recovery occurring within the first three 
months. There were no between group differences at three and six months. The authors (de Jong-
Hagelstein et al. 2011) suggested that the low level of early aphasia therapy intensity and the fact 
that the two therapy types were not sufficiently different may have contributed to the findings.    
Two published randomised controlled trials (RCTs) showed that very early aphasia therapy 
is feasible (Godecke et al. 2012; Laska et al. 2011). The Scandinavian study by Laska et al. (2011) 
and the Australian equivalent study by Godecke et al (2012) were strikingly similar in design, 
baseline aphasia severity, therapy intensity and overall amount of intervention. The studies 
differed in the type of therapy provided to the intervention groups and the overall outcome of these 
studies was disparate. The difference in the nature of the treatment approaches and the outcome 
measures used in these studies may explain some of the discrepancy in the reported results.  
Stroke severity in the Scandinavian study appears to be slightly less than that of the 
Australian study, despite participants being recruited and treated within the first two weeks post 
stroke in both studies. Participants in the Laska et al. (2011) trial received either daily Language 
Enrichment Therapy (LET) or no therapy for the period of intervention. LET comprised exercises 
for comprehension with some (though limited) naming tasks included. The intervention group in 
this study received a minimum of 10 hours and a maximum of 12.5 hours of direct therapy over 15 
working days. The control group received no speech and language therapy for the intervention 
period of the study. After controlling for baseline aphasia and stroke severity, Laska et al. (2011)
 
found no significant difference between those who received LET and those who received UC, on 
the ANELT.  
In comparison, the Australian study
 
(Godecke et al. 2012) provided impairment-based 
therapy which targeted increased verbal production and connected speech using predominantly 
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Semantic Feature Therapy
 
(Boyle & Coelho, 1995) or a combination of Semantic Feature Therapy 
(SFT) and BOX therapy (Visch-Brink, Bajemal & van de Sandt-Koenderman, 1997), or SFT and 
Mapping therapy (Schwarts et al. 1994). Each therapy session also included a picture description 
task which was used to enhance verbal output through a structured and supported conversational 
approach. The intervention group in Godecke et al.
 
(2012) received an average of 5.6 hours of 
direct therapy provided by a speech-language therapist over an average of 7.5 working days 
(overall mean length of stay – 22 days). Participants (and families) received education, 
counselling, case management and discharge planning however these data were not included in the 
5.6 hours of direct therapy. Twenty-three (85%) of the 27 participants in the UC group in this trial 
received no therapy during the intervention phase (22 days) (Godecke et al. 2012). The four 
participants in UC who were treated received on average less than 14 minutes of 1:1 direct therapy 
per week and therapy tasks matched those used in the intervention group.
 
Godecke et al. (2012) reported that those receiving daily therapy showed immediate and 
positive effects of very early aphasia therapy when compared with UC participants. Unfortunately 
due to the application of mixed therapy types for participants in this study, little can be said about 
the effects of discrete therapy types in this recovery phase.  
The pragmatic randomised controlled trial (ACTNoW) by Bowen et al (2012a) compared 
enhanced speech and language therapy (SLT) with attention control (AC) in stroke survivors with 
aphasia and dysarthria. The intervention in this trial commenced on average 15 days after hospital 
admission for acute stroke and lasted for 16 weeks. The intervention group received a less 
intensive (or dispersed) therapy regimen of a mean of 1.3 hours of SLT per week over 16 weeks 
(18 hours total) when compared to Laska et al. 2011 and Godecke et al. 2012 who provided more 
intensive therapy over a shorter duration. More importantly, the 1.3 hours of intervention time 
recorded in the ACTNoW study incorporated all elements of communication intervention which 
included assessments, provision of communication materials and education, carer contact, indirect 
patient contact and direct therapy (Bowen et al, 2012b). Consequently, when compared to other 
studies which demonstrated a positive therapy effect, (de Jong-Hagelstein et al. 2011; Godecke 
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2012; Sickert et al. 2013) participants in the intervention arm of ACTNoW received substantially 
reduced direct therapy intensity.  
The AC group in ACTNoW received an average of 15 hours of social contact from a paid 
visitor over 16 weeks (Bowen et al, 2012b). The intervention for the AC group consisted of a 
structured program including: i) rapport building of 2-4 sessions, ii) regular contact sessions 
involving conversation, the visitor reading from books, magazines, newspapers to create 
conversation topics, watching tv, listening to music, playing games of tactics and strategy or 
creative activities such as crafts or gardening and iii) winding down sessions (2-4 sessions) which 
included preparation for the visitor’s time with the participant to come to an end. At six months 
post stroke, this study found no significant difference in communication outcomes, between those 
in the SLT intervention group and those who received the attention control intervention.  
 More recently, Sickert et al. (2013) completed a single-blind RCT investigating a modified 
dose of intensive aphasia therapy in first-ever stroke survivors when therapy was started in the 
sub-acute phase (mean of 34.8 days post-stroke). One hundred participants with mild to Global 
aphasia were randomised to either CIAT or standard treatment. Treatment for both groups was 
provided for 2 hours per day over 15 (working) days for a total of 30 hours of therapy or a mean of 
10 hours per week. CIAT was provided as per Pulvermuller et al. 2001 with the addition of the use 
of conventional treatment in a group setting (p.2). “Standard treatment consisted of aphasia 
exercises including sentence completion, improving patients’ retrieval of words, learning sentence 
patterns, conversation on current topics, listening to words, and repeating and following 
instructions”. (p.2) 
At therapy completion the authors found both groups made significant recovery on all sub-
tests of the Aachener Aphasia Test (Huber, Poeck, Weniger et al. 1983). Twenty-six of the original 
100 participants were reassessed at eight weeks and one year post-stroke and the authors report 
further significant gains at both time points with no between group significance. Therefore they 
concluded that both CIAT and standard therapy lead to significant improvements in language 
function and that people in the sub-acute phase of recovery tolerated two hours of therapy each 
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day for three weeks (five days per week), regardless of aphasia type/severity (classification) 
(Sickert et al. 2014, pg.5). 
Limitations of existing aphasia research and future research directions  
 While preliminary research for early aphasia intervention has shown positive results (de 
Jong-Hagelstein et al. 2011; Godecke et al. 2012; Sickert et al. 2013) there is no evidence (Brady 
et al. 2012) to support the efficacy of very early post-stroke aphasia treatments in the long-term. 
This is a result of limitations in study methodology, difficulties with participant selection, reduced 
sample size, inconsistent application and description of aphasia therapy types and use of low 
intensity aphasia rehabilitation.  
  
Aims 
This study aimed to show that a prescribed, standardised and intensive very early aphasia 
therapy regimen would provide better communication outcomes when compared to a historical 
usual care control cohort at therapy completion. In doing so this study aimed to validate previous 
positive very early rehabilitation (VER) findings related to therapy type, therapy intensity, and 
overall amount of direct therapy. 
Methods 
Design 
This study compared the communication outcomes of two independent cohorts in the very 
early post-stroke recovery phase. The primary endpoint for this study was at therapy completion 
(four to five weeks post stroke) and follow up was at 26 weeks post stroke.  
The intervention cohort (VER, n=20) was taken from a study that controlled for therapy 
intensity in very early aphasia rehabilitation. The historical usual care (UC) comparison (n=27) 
was derived from a previous RCT reported in full in Godecke et al. (2012). Ethical approval was 
obtained from hospitals before each study commenced. 
Setting 
VER Cohort: Participants in this study were identified from patients admitted to either 
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Royal Perth Hospital (RPH) or Sir Charles Gairdner Hospital (SCGH) in metropolitan Perth, 
Western Australia between December 2008 and September 2009. Both facilities are acute care 
teaching hospitals with over 400 stroke admissions each year. Stroke specific subacute 
rehabilitation was provided by RPH – Shenton Park Rehabilitation Hospital and Osborne Park 
Stroke Rehabilitation Unit (OPH), as required. Therapy was initiated in the acute facility as soon 
after recruitment as possible. Therapy continued without interruption or re-assessment on transfer 
to the subacute facility. The treating therapists changed from acute to post-acute setting however 
the participants' therapy was seamless. 
Control Cohort: Participants were recruited from RPH, SCGH and Fremantle Hospital 
(FH) between 2000 and 2003. Participants in this cohort were assessed at a mean (SD) of 3.4 (2.2) 
days post-stroke and the intervention period commenced the day following assessment. Stroke 
specific and general rehabilitation was provided by metropolitan sub-acute sites as required. 
Participant recruitment 
Both studies: Participants for both studies were identified from the hospital generated daily 
admissions list from each recruiting hospital. Medical notes were screened for all admissions with 
diagnoses of stroke, falls, headache, confusion and seizures on the day of admission or the next 
working day. Patients with a possible or confirmed stroke were identified as prospective study 
participants. Prior to enrolling in each study, all candidates and their families/Next of Kin (NoK) 
were informed that the main goal of each project was to increase the accuracy and amount of 
verbal output.  
Inclusion criteria 
The following criteria were identical for both studies: i) aphasia caused by an acute stroke 
as outlined by Warlow et al. (2001) and diagnosed by a neurologist or stroke physician, ii) a 
clinical stroke diagnosis confirmed by computer tomography and/or magnetic resonance imaging 
within 48 hours of hospital admission, iii) aphasia identified by a score of less than 13/20 on the 
shortened Frenchay Aphasia Screening Test (FAST) (Enderby, Wood & Wade, 1987) which is a 
reliable and valid aphasia screening tool comprising auditory comprehension and verbal 
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expression tasks used to identify aphasia in the early phase of recovery, iv) medical stability 
(measured by the Glasgow Coma Scale score of >10 which indicates moderate level of alertness), 
v) wakefulness – able to maintain sufficient alertness to interact for 30 minutes and vi) aphasia 
severity score (less than 93.8 on the Aphasia Quotient (AQ) of the Western Aphasia Battery 
(WAB)
 
(Kertesz, 1989). The VER cohort selection criteria were broadened slightly from that of the 
Control cohort in Godecke et al (2102) to include people with fluent English and those who were 
appropriate for the study up to fourteen days post stroke onset. A comparison of selection criteria 
for each trial is presented in Table 1.  
Insert Table 1 about here. 
The exclusion criteria for both trials were: i) a previous diagnosis of aphasia, mental illness or 
dementia, ii) a previous history of sub-arachnoid and/or sub-dural haemorrhage or neurosurgical 
intervention and iii) uncorrected hearing or vision impairment. 
Baseline data   
Patient characteristics including demographic factors, stroke features, stroke classification 
according to Oxfordshire Community Stroke Project Classification (Bamford et al. 1991) and the 
modified Rankin Scale (mRS) (Rankin, 1957) were collected at baseline for both studies. Table 2 
shows the baseline characteristics and comparisons for the VER and control cohorts.  
Insert Table 2 about here. 
Speech and Language service delivery and direct aphasia therapy intensity  
 Participants in each study received dysphagia management, patient and family education 
(for example education regarding stroke, secondary prevention, aphasia, and dysphagia), 
counselling and support, case management, discharge planning and all other interventions as they 
required. These data were collected but only the direct aphasia therapy data are presented in this 
paper. 
VER Cohort: Therapy was commenced as soon as possible after recruitment and assessment. 
Intervention started on or before day 14 post-stroke for all participants. The target therapy regimen 
was defined as between 900 and 1200 minutes (15-20 hours) therapy, provided over five days per 
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week for a total of 20 sessions in four weeks (4-5 hours of therapy per week). All attempts were 
made to complete the 20 therapy sessions within four working weeks (Monday -Friday) the fifth 
week was made available to complete any outstanding sessions. If more than two sessions were 
missed in any week, the participant was deemed as not tolerating the intervention. Six trained non-
assessing speech pathologists treated the participants.  
UC Cohort: This cohort (N=27) received an average of 11 minutes of therapy per week for an 
average of three weeks (22 days).  
Type of aphasia therapy provided in each trial 
The therapeutic approaches used in both studies adhered to the general principles of 
neurorehabilitation. Therapy types were designed for use with people with mild aphasia through to 
severe global aphasia. The therapies provided in each trial were impairment-based and believed to 
harness neural recovery through restitution via high frequency (massed practice), use-dependent, 
task-specific repetition (Berthier & Pullvermuller 2011). Strategies to minimise speech production 
errors and to promote self-correction were used to enhance correct production of speech and 
language targets. The speech pathologist pre-empted and avoided consistent task failure to ensure 
participants were supported as needed. This support included prompting, modelling and cueing to 
produce an appropriate verbal response. These strategies are thought to enhance ‘synchronous 
neuronal firing’ to strengthen neural networks and minimise independent neuronal activation that 
could potentially produce maladaptive behaviours (Berthier & Pulvermuller, 2011).  
VER cohort: Participants in this study received either group or 1:1 therapy. Group therapy 
consisted of Constraint Induced Aphasia Therapy (CIAT)
 
(Pulvermuller et al. 2001) in a modified 
dose. Individual therapy consisted of Semantic Feature Therapy (SFT) (Boyle & Coelho 1995), 
Cued Naming therapy (Nettleton & Lesser 1991), Lexical-semantic (BOX) therapy (Visch-Brink, 
Bajema & vande Sandt-Koenderman (1997), Mapping therapy (Schwartz et al. 1994) and/or 
Phonological Feature Therapy (Raymer et al. 1993).  
Treatment integrity was addressed by training all treating therapists to ensure equivalent use 
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of stimuli and therapy type and therapy targets were identical across all therapy sites. All therapy 
tasks (CIAT and 1:1) were structured to promote and scaffold connected speech production.  
CIAT (Group) 
Therapy was based on the CIAT outlined by Pulvermuller and colleagues (2001). The 
therapy took place in small groups of 2-4 participants and one speech pathologist who provided 
language support appropriate to each participant's needs. The stimuli and language support were 
designed to accommodate all levels of aphasia severity in the same group. The group members 
were dealt a set of picture cards, the aim being to collect pairs of cards. Each pictured item 
allowed a verbal response ranging from a single word to complex sentences. Barriers prevented 
the participants from seeing each other's cards. The ‘constraint' of the therapy was provided by the 
requirement of verbal-only interaction. The group language dynamics included politeness markers, 
requesting items, listening, clarification of other’s responses and negating requests. The 
complexity of verbal output required from each participant and the level of cueing and support 
provided was tailored to each individual’s communicative ability as established at assessment and 
through ongoing performance within therapy sessions.  
Individual therapy (1:1) 
Each participant receiving 1:1 therapy had a program tailored to suit their needs. Based on 
the participant's assessment results, the treating therapist selected the appropriate therapy from 
those previously listed.  All 1:1 therapies were provided as per published instructions (Boyle & 
Coelho 1995, Nettleton & Lesser 1991, Visch-Brink et al. 1997, Schwartz et al. 1994, Raymer et 
al. 1993). Participants received either a single therapy, or a combination of therapy types such as 
cued naming therapy and semantic feature therapy.  
Control cohort:  
As previously outlined, 85% of participants in this cohort received no direct therapy. When 
participants received therapy it consisted of individual (1:1) cognitive-neuropsychological and 
neurolinguistically based therapy. Therapists used one or more of the following therapies: lexical-
semantic (BOX) therapy (Visch-Brink et al 1997), Mapping therapy
 
(Schwartz et al 1994) and 
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Semantic Feature Therapy (Boyle & Coelho 1995). Participants also attempted a picture 
description task aimed at increasing connected speech in a supported and structured environment. 
See Godecke et al. (2012) for further detail.  
Recording of speech pathology service delivery data 
The type and duration of speech pathology interventions for both studies were recorded via 
the Allied Health System (AHS). This software package records intervention in five minute units. 
All interventions for each participant were coded for aphasia/dysphagia/dyspraxia/dysarthria and 
time spent in each activity was categorised into assessment, therapy, education/counselling, case 
planning/consultation and documentation. 
Outcome assessment 
Both cohorts were assessed at acute hospital admission, immediately following intervention 
(after four-five weeks therapy) and 26 weeks post stroke. All assessments were completed and 
analysed by blinded assessors. 
Primary Outcome Measures  
The primary outcome measures were the AQ score of the Western Aphasia Battery (WAB) 
(Kertesz, 1982) and the Discourse Analysis (DA) score at therapy completion. All discourse 
samples were collected as per Godecke et al. (2012) and consisted of picture descriptions, personal 
and procedural narratives (Kertesz, 1982; Nicholas & Brookshire, 1995). DA is the total percent 
Correct Information Units produced s per minute (% CIU/MIN) per sample and is calculated by 
dividing the total %CIUs (Nicholas & Brookshire, 1995) by the total time taken to produce the 
discourse. The measure adds a communication efficiency/temporal element
 
that is considered an 
important communicative measure not captured in the AQ scores. CIUs are topic specific words 
that provide detail and are not repetitious, exclamatory, additive or commentary in nature 
(Nicholas & Brookshire, 1995). A count of 200 or more intelligible words across picture 
description, personal and procedural narrative tasks was required for a representative and reliable 
speech sample.  
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All discourse samples for the VER cohort were audio-recorded using a lapel microphone and 
digital recorder (Olympus-DM550). The recordings were transcribed verbatim and analysed as per 
Godecke et al (2012).  
Secondary outcome measures 
 Secondary outcomes were the AQ (Kertesz, 1982) score and DA score at six months post 
stroke. 
Statistical analyses 
 The VER and UC cohorts were compared at baseline using two-tailed t-tests and chi-square 
tests for independence. Generalised estimating equations (GEE) models were developed to 
compare the cohorts on AQ and DA scores at therapy completion and at 26 weeks post stroke. 
Generalized linear models are a class of statistical model that extend the general linear model 
(regression, ANOVA and ANCOVA) to handle non-normal data. Generalized estimating equations 
are a further extension of generalized linear models to account for longitudinal and clustered data. 
GEE models are preferred to repeated measures ANOVA approaches because of their flexibility in 
modelling complex covariance structures that arise in longitudinal and clustered data. 
Furthermore, GEE models are robust against misspecification of the covariance structure and are 
also more robust than repeated measures ANOVA in handling missing data (Ballinger 2004). GEE 
have also been found to be more efficient in that they are able to achieve higher power with 
smaller sample size or lower number of repeated measurements in both complete and missing data 
scenarios (Ma, Mazumdar & Memtsoudis, 2012). In the current work, separate GEE models were 
developed to compare the cohorts on the primary outcome measure (AQ) and the secondary 
outcome measure (DA). Missing data were treated with the last observation carried forward 
approach where appropriate. This complies with the intention to treat principle (Jansen et al. 
2006). 
Due to the possible ceiling effect in the AQ score, the AQ model involved transforming these 
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scores to the percent of maximum potential recovery (AQ%MPR) as per Lazar et al, (2010). The 
score for each participant was calculated as the ratio of the achieved improvement in AQ to the 
maximum achievable improvement at baseline. The ratio was then multiplied by 100 to convert it 
to a percentage score.  
There was a larger number of people with mild aphasia in the VER cohort (n=6; 30%) than 
in the UC cohort (n=3; 11%) and therefore the two cohorts were expected to significantly differ on 
baseline aphasia severity. Since baseline aphasia and stroke severity/disability are universal 
predictors of aphasia recovery, the baseline AQ and mRS (Rankin, 1957) scores were included as 
covariates in both GEE models to control for these differences. Baseline DA was not included as a 
covariate in the models because it was correlated with baseline AQ (r = 0.6, p < 0.001).   
Results 
Baseline 
Over the ten month recruitment period for the VER cohort, the medical notes of 1006 
admissions to Royal Perth Hospital were screened for collapse, falls, seizures, headache, confusion 
and stroke. A total of 236 people were admitted with an acute stroke with 88 (37.2%) of these 
people having confirmed aphasia. We recruited 18 (20.4%) of the people with confirmed aphasia 
from Royal Perth Hospital to this study. Two participants from Sir Charles Gairdner Hospital met 
the selection criteria and were recruited taking the total number of participants to 20. The majority 
(n = 17; 85%) of participants in the VER cohort required full assistance (including aphasia friendly 
forms) to complete the informed consent procedure. 
The baseline characteristics between VER and UC cohorts were not significantly different 
except for the time to initial assessment and baseline AQ score. The VER cohort had a mean age 
(±SD) of 70.7 (+14.3) years and was slightly older than the UC cohort who had a mean age of 67.7 
(+15.4) (Table 2). Ninety percent of the VER cohort had an ischaemic stroke compared to 89% of 
the UC cohort. The majority of the VER cohort (80%) and the UC cohort (82%) had severe stroke-
related disability as indicated by a score of 4 or 5 on the modified Rankin Scale (mRS). A clinical 
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but non-significant difference in the mRS is noted. The difference in the time to initial assessment 
reflects an increase in the length of time to recruitment for the VER cohort which included people 
with aphasia who were recruited up to 14 days post-stroke.  
The difference in baseline AQ scores is reflective of the increased number of people with mild 
aphasia in the VER cohort (n=6; 30%) when compared to the number of people with mild aphasia 
(n=3; 11%) in the UC cohort. Table 2 shows the baseline characteristics and comparisons for the 
VER and UC cohorts.  
Two (10%) of the 20 participants in the VER cohort did not reach the minimum intervention 
requirement (both participants were randomised to receive 1:1 intervention). One participant 
suffered a further stroke after completing a single 40 minute session of therapy. The second 
completed 13 sessions and 780 minutes (13 hours) of therapy, then suffered a gastric haemorrhage 
and was unable to complete the intervention. Table 3 outlines the therapy compliance for 
participants in the VER and control cohorts. Table 4 shows group raw and transformed scores at 
baseline, therapy completion and follow up. The participants in the VER study tolerated 
approximately 4.25 hours of therapy per week for an average of 4.5 weeks (32 days). During this 
time, the average number of therapy sessions was 18.65, and each session averaged 53.5 minutes.  
Insert Table 3 about here. 
Twenty-three of the 27 participants (85%) in the UC cohort received no direct therapy during 
the intervention period (Godecke et al. 2012) (Table 3). The collective amount of direct therapy 
time provided to the four UC participants who received aphasia therapy was 295 minutes (4.9 
hours) over 7 sessions, equating to an average of 11 minutes of therapy per week for each of the 
UC participants.  
Insert Table 4 about here. 
Primary End-Point 
The GEE models showed (see Tables 5 and 6) that after controlling for baseline aphasia 
severity and stroke related disability, VER was a significant predictor of recovery on the AQ 
(p=0.006) and on the DA score (%CIU/Min) (p=0.034). Specifically, participants receiving VER 
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achieved 18 percent greater recovery on AQ and 1.5 percent more on the DA score (%CIU/Min) 
than those in the UC Cohort at therapy completion. These results indicate that people who received 
VER had improved communication impairment measures (AQ%MPR) on standardised testing 
(AQ scores) and produced significantly more accurate and efficient verbal language (DA scores) 
than those who received UC at therapy completion. Table 4 outlines the descriptive data for the 
AQ, DA and the AQ percent of maximum potential recovery (AQ%MPR) scores for the VER and 
UC cohorts at baseline, post therapy and 26 weeks post stroke. As expected, these data indicate 
that the historical UC cohort had more severe communication impairment at baseline than the 
VER cohort. When the AQ data are transformed to (AQ%MPR), baseline scores are returned to 
zero corresponding to a maximum potential recovery of 100% for each participant.   
Insert Tables 5 and 6 about here. 
Follow-up 
At follow-up assessment 26 weeks post-stroke, the GEE model (see Tables 5 and 6) for AQ 
showed that after controlling for baseline aphasia severity and stroke related disability, participants 
receiving VER maintained a statistically significant advantage in recovery (p=0.017) over those 
receiving UC, with the VER cohort scoring 16 percent higher on the AQ than those who received 
UC (Figure 1).  The difference between the cohorts on DA scores was not statistically significant 
(p=0.249) at the six month follow up. However, the VER cohort showed 0.6 percent greater 
recovery on DA than the UC cohort (Figure 2). The dosage of aphasia therapy was not controlled 
after the four-five week intervention period, and participants from both cohorts received UC 
therapy as per their available services.  
Insert Figures 1 and 2 about here 
 
Discussion 
The present study showed that impairment-based aphasia therapy provided by a speech 
pathologist for 45-60 minutes per day for up to 20 sessions, commencing in the first two weeks of 
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stroke recovery, improved communication outcomes at therapy completion in people with mild, 
moderate and severe aphasia when compared to a historical usual care control. Interestingly, the 
communication gains achieved for those treated in the very early recovery period were sustained at 
six months when measured by the AQ score, but despite a clinically meaningful improvement in 
the DA score at six months, this outcome did not reach statistical significance.   
Therapy intensity 
Only the hours of direct patient therapy have been reported in this study, in Laska et al. 2011 
and in Godecke et al (2012). In comparison, Bowen et al. 2012 reported on all aspects of speech 
and language intervention as contributing to therapy intensity. When considering direct aphasia 
therapy only, Laska et al. (2011) and Godecke et al. (2012) provided an average of 3.75 and 3.6 
hours per week respectively; this study provided an average of 4.25 hours per week; Bowen et al. 
(2012b) provided 1.3 hours (combined intervention) per week and Sicket et al. (2013) provided 10 
hours per week in the sub-acute recovery phase. The total amount and duration of the intervention 
in each trial varied, and the outcomes of these studies were mixed. Previous reviews (Bhogal et al. 
2003; Robey, 1998) have found that an average of 2.5 - 5 hours of aphasia therapy per week 
produced significantly better communication outcomes than therapy provided at lower intensity 
level. The results of this study support previous work that highlights the importance of therapy 
intensity in enhancing spontaneous recovery in very early aphasia after stroke. An interesting point 
to also consider here is that people with aphasia in very early recovery can and do tolerate daily 
aphasia therapy of up to 60 minutes per day if the service is provided. 
Therapy type 
Therapy for the VER participants was structured, tailored therapy, based on psycholinguistic 
principles and targeted verbal production (output) at the impairment level of communication. 
People in this study who received very early intervention, consisting of either 1:1 or group therapy 
demonstrated superior communication outcomes at therapy completion and at six months (AQ 
scores) when compared to the historical control group. Results of this study support de Jong-
Hagelstein et al. 2011; Godecke et al. 2012 and Sicket et al. 2013 which show positive results 
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using a variety of therapy types. No research to date has determined the most beneficial therapy 
type for the various aphasia severities and types. A definitive answer to address this complex issue 
is expected to be some time off and will likely require the pooled efforts of multiple data sources. 
DA score at six months 
The very large clinically meaningful but non-significant improvement in the mean DA 
scores in the VER group when compared to the UC group at the same period is an interesting 
finding (Table 4). Seeing a 25% improvement in any score is a welcome result, (Figure 2) 
especially if that score represents: i) the accuracy and efficiency of connected speech and ii) the 
amount of improvement that was made when recovery is thought to be all but completed (Lazar 
2010). The factors that contribute to this recovery remain unclear. The fact that this amount of 
clinical change does not represent a statistical difference is likely to be multifactorial and is best 
explained through the large natural variation seen in the standard deviations, coupled with the 
small sample size in the study.  
Study Limitations 
Due caution regarding the comparative use of a historical control group is warranted given 
that the original population from which the samples in the VER and control cohorts are taken are 
at least five years apart. We acknowledge improvements in the systems of hospital care are likely 
to have occurred in the period 2000-2009 when these data were collected. These changes are likely 
to include increased rates of thrombolysis, improved management of stroke related complications 
and reduction of stroke related morbidity and mortality. It is also possible that these changes will 
have contributed in some way to the results presented here. Unfortunately, the large scale systems 
audit required for monitoring service delivery and organisational changes in stroke services was 
not available at the time these data were collected. Some reassurance is provided, given the fact 
that there was no statistical between group significance in stroke type, stroke classification and 
mRS score between the VER and control cohorts at baseline. 
The VER rehabilitation study design would have been strengthened by including a third 
arm of randomisation that measured usual care alone and with stratification of aphasia severity. 
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Additionally, the results of the VER cohort should be interpreted with caution due to the small 
number of participants who completed the six month follow-up. Whilst the statistical modelling 
for this paper was conservative and vigilant, the highly variable nature of aphasia requires large 
scale clinical trials before clinical efficacy and/or effectiveness can be established. 
 
Conclusion and future directions 
Very early, impairment-based aphasia therapy resulted in superior communication outcomes 
which were sustained at six months post-stroke when compared to a historical control cohort. This 
paper provides support for very early impairment-based aphasia therapy provided between 45-60 
minutes per day, when commenced within the first two weeks post-stroke. Importantly this study 
found the timing and intensity of very early therapy is feasible and beneficial for people with mild 
to severe aphasia (Godecke et al, 2012).  It also adds evidence to suggest that increased aphasia 
therapy (intensity, frequency and amount) in the very early and early recovery phases is important 
for augmenting the effects of spontaneous recovery.  
Given the ongoing debate surrounding the benefits of very early aphasia intervention, we 
must focus further research attention to unpacking the elements of the optimal aphasia therapy 
type, intensity, and timing to best facilitate the natural mechanisms of very early aphasia recovery. 
If healthcare funding bodies are to be convinced of the benefits of very early aphasia rehabilitation 
we must determine the right combination of aphasia therapy for the right person, provided at the 
right time.   
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Table 1.    Variation in selection criteria for the VER and Control cohorts  
  
  VER cohort Control cohort  
     
Admission to hospital (days) <14 <10 
Frenchay Aphasia Screening test (days) <14 <10   
Conscious/Medically stable (days) <14 <10  
Wakeful state >30 minutes (days) <14 <10 
Aphasia severity Mild –Severe Mild - Severe 
English as a second language yes no    
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Table 2.   Baseline demographic and stroke characteristics and comparisons for the VER and 
control cohorts  
 
   VER Control p value 
   cohort  cohort 
  n = 20  n = 27  
     
Age Mean (SD) 70.7(14.3) 67.7(15.4) .499*
‡
  
Female (%)   8 (40) 12 (44)  .761
†
 
Previous Stroke 
 Yes   3   3  
 No 17 24 
Stroke type    .903
†
 
 Ischaemic (%) 18 (90) 24 (89)  
 Haemorrhagic (%)   2 (10)   3 (11)    
Stroke classification    .298
†
 
 PACI (%)   1 ( 5 )   9 (33.5)   
 TACI (%) 17 (85) 14 (52) 
 PoCI (%)   0  1   (3.5) 
 LACI (%)   0  0 
 Non-classified
 
  2 (10)  3  (11) 
Stroke Hemisphere:  
 Left  (%) 18 (90) 26 (96) 
 Right  (%)   2 (10)   1 ( 4) 
Mortality within 28 days 
 Number (%) 1 (5) 3 (11)  .458
†
 
Admission mRS score: Number (%)      .676
†*
 
 2   1 (5)   1 (3)  
 3   3 (15)   4 (15)  
 4   9 (45)   8 (30)    
 5   7 (35) 14 (52) .898
†^
 
Admission to assessment  
 Mean days (SD)  6.1 (2.3) 3.4 (2.2) .000
‡
 
 
PACI: partial anterior circulation infarct; TACI: total anterior circulation infarct; PoCI: posterior circulation 
infarct LACI: Lacunar infarct; Non-classified = haemorrhage  
   † 
Chi-Square test for independence 
*‡ 2tailed t-test comparing Very Early Rehabilitation cohort with Control cohort 
   * 
Overall mRS score comparison 
 ^ mRS categorised comparisons: Categories 2-3 indicate mild to moderate disability;  
    Categories 4-5 indicate severe disability 
 
 26 
 
 
 
Table 3.   Descriptive data for intervention compliance, total therapy time (minutes) and number 
of sessions in the intervention phase 
 
Therapy details VER cohort Control cohort  
 n = 20 n= 27  
Met intervention compliance 18 (90%) n/a 
 
Received therapy 20 (100%) 4 (15%) 
   
Intervention phase language therapy (total mins) 
 Mean (SD) 1070.25 (267.44) 10.92 (38.73)* 
 Median (IQR) 1167.5 (131.25) 47.5(86.25) 
   
Intervention phase language number of therapy sessions     
 Mean (SD) 18.65 (4.44) 0.3 (.99) 
 Median (IQR) 8 (5.25) 1 (.75) 
  
* indicates the overall mean for all participants (n=27) in control cohort  
   IQR – interquartile range 
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Table 4.  Group raw-scores comparisons for communication outcomes between Very Early 
Rehabilitation participants and the Control Cohort. 
 
  VER Cohort Control Cohort p-vlaue* 
      
Baseline AQ 
 Number of participants 20 27   
 Mean (SD) 43.53 (27.02) 19.62 (26.26) .009 
Therapy completion AQ 
 Number of participants 17 24 
 Mean (SD) 67.55 (30.16) 31.37 (32.83) .001 
Follow-up (26 weeks) AQ 
 Number of participants 8 23  
 Mean (SD) 89.01 (11.96) 45.62 (39.64) .001 
 
Baseline AQ%MPR      
 Number of participants 20 27  
 Mean (SD)  n/a  n/a  n/a 
Therapy completion AQ%MPR 
 Number of participants 17 24  
 Mean (SD) 46.72 (35.43) 17.92 (23.18) .007 
Follow up (26 weeks) AQ%MPR 
 Number of participants 8 23  
 Mean (SD) 77.60 (20.45) 38.77 (37.08) .002 
 
Baseline DA      
 Number of participants 20  27  
 Mean (SD) 3.26 (5.0) 1.18 (4.06) .123 
Therapy completion DA 
 Number of participants 17 24  
 Mean (SD) 8.36 (8.54) 2.37 (5.60) .012
 
Follow up (26 weeks) DA 
 Number of participants 8 23  
 Mean (SD) 33.90 (17.9) 7.74 (12.87) .004 
 
n.b These scores are unadjusted for baseline differences in aphasia severity and stroke disability.  
 * t-test; significance p=.005
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Table 5. GEE Model for Percent of Maximal Potential Recovery on AQ 
 
Parameter Estimate 
Std. 
Error 
Confidence 
Limits 
Lower      Upper 
Wald 
Chi-Square 
p-value 
Baseline AQ .32 .09 .15 .49 13.96 .000 
Baseline mRS -2.64 2.94 -8.41 3.14 .801 .371 
Primary End-point 17.70 4.58 8.73 26.68 14.94 .000 
Follow-up 39.21 7.46 24.59 53.82 27.65 .000 
VER -8.27 3.19 -14.52 -2.01 6.71 .010 
Primary End-point * VER 26.19 9.52 7.52 44.86 7.56 .006 
Follow-up * VER 24.22 10.17 4.28 44.15 5.67 .017 
n.b  Primary End-point: Therapy Completion (4-5 Weeks post-stroke);  
 Follow-up: 6 months post-stroke; VER: Very Early Rehabilitation Group; Primary 
 End-point * VER: Very Early Rehabilitation group compared to Usual Care group at 
 Therapy Completion; Follow-up * VER: Very Early Rehabilitation group compared to 
 Usual Care Group at 6 months 
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Table 6. GEE Model for Recovery on DA 
 
Parameter Estimate 
Std. 
Error 
Confidence Limits 
Lower      Upper 
Wald 
Chi-Square 
p-value 
Baseline AQ .20 .03 .146 .26 49.62 .000 
Baseline mRS -.51 .94 -2.34 1.33 .29 .590 
Primary End-Point .53 .81 -1.06 2.12 .43 .514 
Follow-up 6.21 1.85 2.59 9.83 11.31 .001 
VER -3.05 1.48 -5.96 -.14 4.21 .040 
Primary End-Point * VER 4.56 2.15 .34 8.78 4.49 .034 
Follow-up * VER 3.61 3.13 -2.52 9.73 1.33 .249 
n.b  Primary End-point: Therapy Completion (4-5 Weeks post-stroke);  
 Follow-up: 6 months post-stroke; VER: Very Early Rehabilitation Group; Primary 
 End-point * VER: Very Early Rehabilitation group compared to Usual Care group at 
 Therapy Completion; Follow-up * VER: Very Early Rehabilitation group compared to 
 Usual Care Group at 6 months 
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           VER cohort 
 
           Control cohort 
Figure 1.  AQ%MPR comparisons at baseline, therapy completion and follow-up (26 weeks) 
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Figure 3.  Discourse Analysis comparisons at baseline, therapy completion and follow-up (26 
weeks) 
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         Control cohort 
 
Figure 2.  DA comparisons at baseline, therapy completion and follow-up (26 weeks) 
 
 
 
 
